enVVeno Medical Corp Operating Lease, Expense
enVVeno Medical Corp (NVNO) reported Operating Lease, Expense of $7.00 thousand for the 0-month period ending 2021-11-17, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-03-26
- 2021-11-17: Operating Lease, Expense 0 month $7.00K; Operating Lease, Expense 0 month as first filed $7.25K.
- 2017-09-20: Operating Lease, Expense 0 month $7.25K.
| Period end | Operating Lease, Expense 0 month | Operating Lease, Expense 0 month as first filed |
|---|---|---|
| 2021-11-17 | $7.00K 10-K · filed 2026-03-26 | $7.25K 10-K · filed 2022-03-28 |
| 2017-09-20 | $7.25K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |